1. Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer. Issue 8 (August 2020) Authors: Harrington, K.J.; Bhide, S.A.; Forster, M.D.; Good, J.S.; Gunn, L.; Kong, A.; Melcher, A.A.; Metcalf, R.; Nenclares, P.; Newbold, K.L.; Nutting, C.M.; Prestwich, R.; Sacco, J.J.; Soliman, H.; Wong, K.H. Journal: Clinical oncology Issue: Volume 32:Issue 8(2020) Page Start: 490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy. Issue 5 (May 2022) Authors: Diez, P.; Hanna, G.G.; Aitken, K.L.; van As, N.; Carver, A.; Colaco, R.J.; Conibear, J.; Dunne, E.M.; Eaton, D.J.; Franks, K.N.; Good, J.S.; Harrow, S.; Hatfield, P.; Hawkins, M.A.; Jain, S.; McDonald, F.; Patel, R.; Rackley, T.; Sanghera, P.; Tree, A. Journal: Clinical oncology Issue: Volume 34:Issue 5(2022) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗